Literature DB >> 33793119

Pitfalls in mononucleotide microsatellite repeats instability assessing (MSI) in the patients with B-cell lymphomas.

Kseniia Andreevna Sychevskaya1, N V Risinskaya1, S K Kravchenko1, E E Nikulina1, A E Misyurina1, A U Magomedova1, A B Sudarikov1.   

Abstract

Analysis of microsatellite instability (MSI) is a routine study in the diagnostics of solid malignancies. The standard for determining MSI is a pentaplex PCR panel of mononucleotide repeats: NR-21, NR-24, NR-27, BAT-25, BAT-26. The presence of MSI is established based on differences in the length of markers in the tumor tissue and in the control, but due to the quasimonomorphic nature of standard mononucleotide loci the use of a control sample is not necessary in the diagnosis of MSI-positive solid tumors. The significance of the MSI phenomenon in oncohematology has not been established. This paper presents the results of a study of MSI in B-cell lymphomas: follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma (HGBL). We have shown that aberrations of mononucleotide markers occur in these diseases, but the nature of the changes does not correspond to the classical MSI in solid neoplasms. This fact requires further study of the pathogenesis of such genetic disorders. Due to the possibility of ambiguous interpretation of the results of the MSI study for previously uncharacterized diseases, strict compliance with the methodology of parallel analysis of the tumor tissue and the control sample is mandatory.

Entities:  

Keywords:  diffuse large B-cell lymphoma (DLBCL); follicular lymphoma (FL); genetic instability; high-grade B-cell lymphoma (HGBL); loss of heterozygosity (LOH); microsatellite instability (MSI); short tandem repeats (STR); “stutter bands” (SB)

Mesh:

Year:  2021        PMID: 33793119     DOI: 10.51620/0869-2084-2021-66-3-181-186

Source DB:  PubMed          Journal:  Klin Lab Diagn        ISSN: 0869-2084


  1 in total

1.  STR Profiling Reveals Tumor Genome Instability in Primary Mediastinal B-Cell Lymphoma.

Authors:  Natalya Risinskaya; Yana Mangasarova; Elena Nikulina; Yana Kozhevnikova; Julia Chabaeva; Anna Yushkova; Aminat Magomedova; Sergey Kulikov; Hunan Julhakyan; Sergey Kravchenko; Andrey Sudarikov
Journal:  Curr Oncol       Date:  2022-05-10       Impact factor: 3.109

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.